Sunil R. Hingorani
Impact in
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 67
- Pancreatic and Hepatic Oncology Research 49
- Cancer Cells and Metastasis 10
- HER2/EGFR in Cancer Research 8
- Cancer Immunotherapy and Biomarkers 8
- Peptidase Inhibition and Analysis 7
- Co-authors
- David A. Tuveson (13 shared papers)Paolo P. Provenzano (4 shared papers)Chelsea Combs (3 shared papers)Ralph H. Hruban (5 shared papers)Carlos Cuevas (3 shared papers)Amy Chang (4 shared papers)Daniel D. Von Hoff (7 shared papers)Vikas Goel (1 shared paper)
- Journals
- Journal of Clinical Oncology (15 papers)Cancer Cell (11 papers)Annals of Oncology (7 papers)Cancer Research (6 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United StatesSouth AfricaRussia
In The Last Decade
Sunil R. Hingorani
86 papers receiving 12.5k citations
Sunil R. Hingorani's Hit Papers
Peers
Comparison fields: 5 of 135
- Oncology 8.1k
- Cancer Research 3.1k
- Immunology 2.6k
- Molecular Biology 5.3k
- Biotechnology 649
Countries citing papers authored by Sunil R. Hingorani
This map shows the geographic impact of Sunil R. Hingorani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil R. Hingorani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil R. Hingorani more than expected).
Fields of papers citing papers by Sunil R. Hingorani
This network shows the impact of papers produced by Sunil R. Hingorani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil R. Hingorani. The network helps show where Sunil R. Hingorani may publish in the future.
Co-authors
The 25 scholars most cited alongside Sunil R. Hingorani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice Hit paper breakdown → | 2005 | 1776 |
| 2 | Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Hit paper breakdown → | 2003 | 1774 |
| 3 | Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2012 | 1585 |
| 4 | ATP citrate lyase inhibition can suppress tumor cell growth Hit paper breakdown → | 2005 | 820 |
| 5 | Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion Hit paper breakdown → | 2007 | 745 |
| 6 | Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects Hit paper breakdown → | 2004 | 626 |
| 7 | HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma Hit paper breakdown → | 2017 | 365 |
| 8 | Suppression of BRAF(V599E) in human melanoma abrogates transformation. | 2003 | 334 |
| 9 | Photostable Ratiometric Pdot Probe for in Vitro and in Vivo Imaging of Hypochlorous Acid Hit paper breakdown → | 2017 | 321 |
| 10 | 2007 | 271 | |
| 11 | 2016 | 262 | |
| 12 | 2013 | 258 | |
| 13 | 2014 | 255 | |
| 14 | 2019 | 241 | |
| 15 | 2009 | 172 | |
| 16 | 2013 | 163 | |
| 17 | 2015 | 156 | |
| 18 | 2015 | 151 | |
| 19 | 2017 | 148 | |
| 20 | 2003 | 129 |
About Sunil R. Hingorani
Sunil R. Hingorani is a scholar working on Oncology, Molecular Biology, Cancer Research, Surgery and Cell Biology, having authored 87 papers that have together received 12.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (49 papers), Cancer Genomics and Diagnostics (11 papers), Cancer Cells and Metastasis (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Pancreatitis Pathology and Treatment (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Oncology (8.1k citations), Cancer Research (3.1k citations), Immunology (2.6k citations), Molecular Biology (5.3k citations) and Biotechnology (649 citations). Sunil R. Hingorani has collaborated with scholars based in United States, South Africa and Russia. Frequent co-authors include David A. Tuveson, Paolo P. Provenzano, Chelsea Combs, Ralph H. Hruban, Carlos Cuevas, Amy Chang, Daniel D. Von Hoff, Vikas Goel, Lifu Wang and Sandy Chang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Cell, Annals of Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.